Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimers Disease

Journal of Alzheimer's Disease

Volumn 26, Issue SUPPL. 3, 2011, Pages 307-319

  Westman, Eric ^b   Wahlund, Lars Olof ^a   Foy, Catherine ^b   Poppe, Michaela ^b   Cooper, Allison ^b   Murphy, Declan ^b   Spenger, Christian ^c   Lovestone, Simon ^b   Simmons, Andrew ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AD; MRI; MRS; multivariate analysis; OPLS

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL CLASSIFICATION; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HIPPOCAMPUS; HUMAN; MALE; METABOLITE; MULTIVARIATE ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

EID: 80055044259     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-0028     Document Type: Article

References (78)

1. Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80, 115-122. (Pubitemid 351448411)
2. OBrien JT (2007) Role of imaging techniques in the diagnosis of dementia. Br J Radiol 80 Spec No 2, S71-S77.
3. Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC (2008) Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. JAmGeriatr Soc 56, 920-934. (Pubitemid 351652416)
4. Scahill RI, Fox NC (2007) Longitudinal imaging in dementia. Br J Radiol 80 Spec No 2, S92-S98. (Pubitemid 351799335)
5. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN (1996) Presymptomatic hippocampal atrophy in Alzheimers disease. A longitudinal MRI study. Brain 119(Pt 6), 2001-2007.
6. Jack CR Jr, Petersen RC, OBrien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimers disease. Neurology 42, 183-188.
7. Jack CR Jr, Petersen RC, Xu YC, Waring SC, OBrien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimers disease. Neurology 49, 786-794. (Pubitemid 27428023)
8. Juottonen K, Laakso MP, Partanen K, Soininen H (1999) Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 20, 139-144. (Pubitemid 30417684)
9. Xu Y, Jack CR Jr, OBrien PC, Kokmen E, Smith GE, Ivnik RJ, Boeve BF, Tangalos RG, Petersen RC (2000) Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 54, 1760-1767. (Pubitemid 30428402)
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239-259.
11. Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M (2006) Four subgroups of Alzheimers disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 33, 17-26. (Pubitemid 44397587)
12. Firbank MJ, Harrison RM, OBrien JT (2002) A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinsons disease. Dement Geriatr Cogn Disord 14, 64-76. (Pubitemid 36152947)
13. Kantarci K (2007) 1H magnetic resonance spectroscopy in dementia. Br J Radiol 80 Spec No 2, S146-S152.
14. Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64, 12-21.
15. Douaud G, Jbabdi S, Behrens TEJ, Menke RA, Gass A, Monsch AU, Rao A, Whitcher B, Kindlmann G, Matthews PM, Smith S (2011) DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimers disease. Neuroimage 55, 880-890.
16. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, JohnsonKA(2010) Functional alterations in memory networks in early Alzheimers disease. Neuromolecular Med 12, 27-43.
17. Chen W, Song X, Beyea S, DArcy R, Zhang Y, Rockwood K (2011) Advances in perfusion magnetic resonance imaging in Alzheimers disease. Alzheimers and Dementia 7, 185-196.
18. Deoni SC, Peters TM, Rutt BK (2005) High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn Reson Med 53, 237-241. (Pubitemid 40110499)
19. McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler JDJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM (2009) Alzheimer disease: Quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251, 195-205.
20. Fan Y, Batmanghelich N, Clark CM, Davatzikos C (2008) Spatial patterns of brain atrophy inMCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 39, 1731-1743. (Pubitemid 351179414)
21. Kloppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS (2008) Accuracy of dementia diagnosis: A direct comparison between radiologists and a computerized method. Brain 131, 2969-2974.
22. Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RSJ (2008) Automatic classification of MR scans in Alzheimers disease. Brain 131, 681-689. (Pubitemid 351294712)
23. McIntosh AR, Lobaugh NJ (2004) Partial least squares analysis of neuroimaging data: Applications and advances. Neuroimage 23, S250-S263. (Pubitemid 39421723)
24. Westman E, Simmons A, Zhang Y, Muehlboeck J, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, K?oszewska I, Soininen H, Lovestone S, Spenger C, Wahlund L, consortium. ftA (2011) Multivariate analysis of MRI data for Alzheimers disease, mild cognitive impairment and healthy controls. Neuroimage 54, 1178-1187.
25. Westman E, Spenger C, Oberg J, Reyer H, Pahnke J,Wahlund LO (2009) In vivo 1 H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci 10, 33.
26. Westman E, Spenger C, Wahlund L-O, Lavebratt C (2007) Carbamazepine treatment recovered low Nacetylaspartate+ N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1 mceph/mceph. Neurobiology of Disease 26, 221-228. (Pubitemid 46436500)
27. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S (2006) Proteome-based plasma biomarkers for Alzheimers disease. Brain 129, 3042-3050. (Pubitemid 44684524)
28. Simmons A, Arridge SR, Barker GJ, Williams SCR (1996) Simulation of MRI cluster plots and application to neurological segmentation. Magnetic Resonance Imaging 14, 73-92. (Pubitemid 26070801)
29. Robertson DMWM, van Amelsvoort TM, Daly EB, Simmons AP, Whitehead MM, Morris RGP, Murphy KCM, Murphy DGMM (2001) Effects of estrogen replacement therapy on human brain aging: An in vivo 1H MRS study. Neurology 57, 2114-2117.
30. Simmons A, Smail M, Moore E,Williams SCR (1998) Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magnetic Resonance Imaging 16, 319-330. (Pubitemid 28264528)
31. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22, 1060-1075. (Pubitemid 38829195)
32. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355. (Pubitemid 34162530)
33. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23 Suppl 1, S69-S84. (Pubitemid 39429376)
34. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87-97. (Pubitemid 128742012)
35. Fischl B, Liu A, Dale AM (2001) Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20, 70-80. (Pubitemid 32293421)
36. Segonne F, Pacheco J, FischlB(2007) Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 26, 518-529. (Pubitemid 46527332)
37. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194. (Pubitemid 29369874)
38. Dale AM, Sereno MI (1993) Improved localizadon of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: A linear approach. Journal of Cognitive Neuroscience 5, 162-176. (Pubitemid 23123842)
39. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97, 11050-11055.
40. Fischl B, Sereno MI, Tootell RB, Dale AM (1999) Highresolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8, 272-284.
41. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968-980. (Pubitemid 44183792)
42. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex 14, 11-22. (Pubitemid 38018050)
43. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund L-O, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2009) Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging. In press, Corrected Proof.
44. Liu Y, Paajanen T, Zhang Y,Westman E,Wahlund L-O, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2010) Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimers disease. Neurobiology of Aging 31, 1375-1385.
45. Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J,Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S (2010) Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimers disease. Mol Psychiatry 2010 Nov 30. Epub ahead of print
46. Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2010) Effect of APOE epsilon4 allele on cortical thicknesses and volumes: the Add Neuro Med study. J Alzheimers Dis 21, 947-966.
47. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A,Tunnard C, SobowT, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, SoininenH(2010)APOEepsilon2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord 30, 229-237.
48. Thambisetty M, Hye A, Foy C, Daly E, Glover A, Cooper A, Simmons A, Murphy D, Lovestone S (2008) Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimers disease. J Neurol 255, 1712-1720.
49. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y,Wahlund LO,Westman E, Kinsey A, Guntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR,Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, OBrien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67, 739-748.
50. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo protonNMRspectra. Magn Reson Med 30, 672-679. (Pubitemid 23360802)
51. ProvencherSW(2001) Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14, 260-264. (Pubitemid 32611437)
52. Ackl N, Ising M, SchreiberYA, Atiya M, Sonntag A, Auer DP (2005) Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimers disease. Neurosci Lett 384, 23-28.
53. Westman E, Spenger C,Wahlund LO, LavebrattC(2007) Carbamazepine treatment recovered low N-acetylaspartate+Nacetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph). Neurobiol Dis 26, 221-228. (Pubitemid 46436500)
54. Bylesjo M, Eriksson D, Kusano M, Moritz T, Trygg J (2007) Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J 52, 1181-1191. (Pubitemid 350237582)
55. Johan Trygg SW (2002) Orthogonal projections to latent structures (O-PLS). Journal of Chemometrics 16, 119-128.
56. Rantalainen M, Cloarec O, Beckonert O,Wilson ID, Jackson D, Tonge R, Rowlinson R, Rayner S, Nickson J, Wilkinson RW,Mills JD, Trygg J, Nicholson JK, Holmes E (2006) Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteome Res 5, 2642-2655. (Pubitemid 44595166)
57. Levine B, Kovacevic N, Nica EI, Cheung G, Gao F, Schwartz ML, Black SE (2008) The Toronto traumatic brain injury study: Injury severity and quantified MRI. Neurology 70, 771-778.
58. Oberg J, Spenger C, Wang FH, Andersson A, Westman E, Skoglund P, Sunnemark D, Norinder U, Klason T, Wahlund LO, LindbergM(2008) Age related changes in brain metabolites observed by (1)H MRS in APP/PS1 mice. Neurobiol Aging 29, 1423-1433. (Pubitemid 351970599)
59. Eriksson L, Johansson E,Kettaneh-Wold N,Trygg J,Wiksröm C,Wold S (2006) Multi-and Megavariate Data Analysis (Part I -Basics and Principals and Applications), Umetrics AB, Umeå.
60. Qizilbash S, Chui, Tariot, Brodaty, Kaye, Erkinjuntti (2002) (Blackwell Publishing, Oxford), 20-23.
61. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F (1993) Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimers disease. Arch Neurol 50, 949-954. (Pubitemid 23275123)
62. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H (1996) Hippocampal volumes in Alzheimers disease, Parkinsons disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46, 678-681. (Pubitemid 26099632)
63. Laakso MP, Soininen H, Partanen K, Lehtovirta M, Hallikainen M, Hanninen T, Helkala EL, Vainio P, Riekkinen PJ Sr (1998) MRI of the hippocampus in Alzheimers disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 19, 23-31. (Pubitemid 28167791)
64. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, Deweer B, Dubois B, Marsault C (1994) Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 15, 929-937. (Pubitemid 24153784)
65. Seab JP, Jagust WJ,Wong ST, Roos MS, Reed BR, Budinger TF (1988) Quantitative NMR measurements of hippocampal atrophy in Alzheimers disease. Magn Reson Med 8, 200-208. (Pubitemid 18259510)
66. Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimers patients from normal elderly controls. Neurobiol Aging 29, 23-30. (Pubitemid 350110605)
67. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP (2001) Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 57, 1669-1674. (Pubitemid 33055487)
68. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS (2002) MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58, 1188-1196. (Pubitemid 34411862)
69. Schulerud H, Albregtsen F (2004) Many are called, but few are chosen. Feature selection and error estimation in high dimensional spaces. Comput Methods Programs Biomed 73, 91-99. (Pubitemid 38134483)
70. Simon Spycher MNJG (2004) Comparison of different classification methods applied to a mode of toxic action data set. QSAR & Combinatorial Science 23, 779-791.
71. Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2008) Alzheimers disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 39, 1186-1197.
72. Plant C, Teipel SJ, Oswald A, Böhm C, Meindl T, Mourao-Miranda J, Bokde AW, Hampel H, Ewers M (2009) Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimers disease. Neuroimage 50, 162-174.
73. Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, Knopman DS, Boeve BF, OBrien PC, Petersen RC, Jack CR Jr (2009) Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72, 1519-1525.
74. Jessen F, Traeber F, Freymann N, MaierW, Schild HH, Heun R, Block W (2005) A Comparative Study of the Different N-Acetylaspartate Measures of the Medial Temporal Lobe in AlzheimeraD TMs Disease. Dementia and Geriatric Cognitive Disorders 20, 178-183. (Pubitemid 41191635)
75. Schuff N, Capizzano AA, Du AT, Amend DL, ONeill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW (2002) Selective reduction of Nacetylaspartate in medial temporal and parietal lobes in AD. Neurology 58, 928-935. (Pubitemid 34242070)
76. Godbolt AK,Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN (2006) MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 66, 718-722. (Pubitemid 43739827)
77. Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ (2008) High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry 32, 786-793. (Pubitemid 351312380)
78. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimers disease. The Lancet 368, 387-403.